BioSpace News Archive

Sharps Compliance Corp. reported financial results for the third quarter and first nine months of fiscal year 2020 ended March 31, 2020.

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that it will release financial results for the first quarter 2020 after the close of trading on Tuesday, May 5.

No cases of inflammation observed after 12 months with Phase 3 formulation of pegcetacoplan in patients with advanced geographic atrophy (GA)

Completed the Phase 1b safety lead-in, identifying recommended Phase 2 dose of BXCL701 in combination with pembrolizumab (KEYTRUDA®) in advanced prostate cancer

Spectral Medical Inc., a late stage theranostic company advancing therapeutic options for sepsis and septic shock, released an update on the impact of COVID-19 on the Company’s business, the measures it has put in place, accordingly, and its long-term strategy.

Part 2 of pivotal study met its primary endpoint by demonstrating unsupported sitting in infants aged 1-7 months with type 1 SMA after 12 months of treatment

US Pharma (Zubsolv® US) net revenues of SEK 163.9 m (161.7), up 1.3 percent in SEK and -4.0 percent in local currency. HQ & Pipeline net revenues of SEK 11.1 m (12.6).

Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases, announced that the cash payments of Board fees will be suspended and replaced with Immuron stock.

Always-On™ surface coating demonstrates first correlation of sustained environmental bioburden reduction and 36% Healthcare-Associated Infection (HAI) declines

Electromedical Technologies, Inc., a pioneer in the development and manufacturing of bioelectronic devices, including the WellnessPro®, designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, is pleased to provide a forecast for expected first quarter performance for 2020.